Anosmia, or loss of smell, has been significantly linked to COVID-19, with studies revealing a high correlation between the two. The potential neuroinvasion of the virus may contribute to acute respiratory failure, while neurological symptoms like dizziness and stroke are becoming increasingly recognized in severely ill patients. Awareness of these symptoms is crucial for better patient management and care.